ASHLEY HASSON: Open Payments
NPI 1063039972 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 54 payments from 13 companies in 2025. Trend: 2023 $280 · 2024 $839 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $450 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Amgen Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $18 |
Products named: VRAYLAR, QULIPTA, CAPLYTA, REXULTI, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, Qelbree.
Industry payments across PA — which companies pay providers there.
